Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors.
Chude CI, Amaravadi RK. · 2017
Read Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors. by Chude CI, Amaravadi RK. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5486101.txt.
Description
Chude and Amaravadi present a review in the International Journal of Molecular Sciences on blocking autophagy in cancer. Autophagy is the cell's recycling system for worn parts and proteins. Advanced tumors lean on that recycling to survive stress. Blocking it could make other therapies bite harder. Lab evidence for the idea keeps growing.
Hydroxychloroquine is the only approved drug that blocks autophagy so far. Trials use it alone and alongside standard treatments. Early results show added tumor shrinkage in lab models. The drug is weak, though, so stronger blockers are in development. The review sorts candidates by the recycling step they target.
Catalog record
| CREATOR | Chude CI, Amaravadi RK. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |